Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
94 participants
INTERVENTIONAL
2013-01-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The development and maintenance of a healthy lifestyle (smoking cessation, healthy nutrition, moderate physical exercises etc.) is a major objective concerning the primary and secondary prevention of cerebro- and cardiovascular diseases. CAPSYS is a computer-based lifestyle coaching system developed by researchers from the Public Research Centre (CRP) Henri Tudor in Luxembourg in collaboration with neurologists from the Centre Hospitalier de Luxembourg (CHL), which aims at supporting patients in performing appropriate behavior changes in order to minimize their individual risk factors. Patients can access CAPSYS by dialing a local-rate telephone number and answer to a set of previously known questions concerning their current nutrition, physical activity, blood pressure, smoking etc. In an interactive voice response approach, questions are issued by the system in natural language using text-to-speech, and the patient can provide the required values using the phone keypad. Based on the gathered values for each patient, the system automatically generates personalized verbal feedback at runtime and presents it to the patient during the phone dialog. Depending on the individual development of the patient's risk factors, the system feedback can contain advice for improvement, praise for healthy behavior and motivation to pursue a certain goal.
The user acceptance and effectiveness of the CAPSYS system is evaluated in a six-month randomized controlled study with participants recruited at CHL's neurology department.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-Stroke Secondary Prevention With Digital Monitoring
NCT06837311
Nutrition and Physical Activity in Patients With Cerebrovascular Disease
NCT01146132
Trustworthy Artificial Intelligence for Improvement of Stroke Outcomes
NCT06710028
The Care of Stroke in Ziekenhuis Oost-Limburg
NCT03355690
BIC: Evaluation of the Current Care Processes for Stroke Care in Flemish Hospitals
NCT05218135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care (SC)
Standard care
Participants receive only the usual care including blood analyses, blood pressure controls and individual advice on healthy lifestyle during the outpatient treatment given by the neurologist, by the general practitioner and by other physicians.
Interventional care (IC)
CAPSYS
In addition to the usual care, patients are asked to call the CAPSYS system twice a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard care
Participants receive only the usual care including blood analyses, blood pressure controls and individual advice on healthy lifestyle during the outpatient treatment given by the neurologist, by the general practitioner and by other physicians.
CAPSYS
In addition to the usual care, patients are asked to call the CAPSYS system twice a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Already suffered a stroke or Transient Ischemic Attack (TIA) or
* At least two risk factors for stroke:
* High blood pressure
* Overweight
* Low physical activity
* Smoking
* Unhealthy diet
Exclusion Criteria
* No signed informed consent
* Dementia
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier du Luxembourg
OTHER
Lübomira Spassova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lübomira Spassova
Dr.-Ing.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lübomira Spassova, Dr.-Ing.
Role: STUDY_CHAIR
Luxembourg Institute of Science and Technology
Debora Vittore
Role: STUDY_CHAIR
Centre Hospitalier de Luxembourg (CHL)
Dirk W Droste, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier de Luxembourg (CHL)
Norbert Rösch, Prof. Dr.
Role: STUDY_DIRECTOR
University of Applied Sciences Kaiserslautern
References
Explore related publications, articles, or registry entries linked to this study.
Spassova L, Vittore D, Droste D, Rosch N. Automated lifestyle coaching for cerebro-cardiovascular disease prevention. Stud Health Technol Inform. 2013;190:234-6.
Crocker TF, Brown L, Lam N, Wray F, Knapp P, Forster A. Information provision for stroke survivors and their carers. Cochrane Database Syst Rev. 2021 Nov 23;11(11):CD001919. doi: 10.1002/14651858.CD001919.pub4.
Spassova L, Vittore D, Droste DW, Rosch N. Randomised controlled trial to evaluate the efficacy and usability of a computerised phone-based lifestyle coaching system for primary and secondary prevention of stroke. BMC Neurol. 2016 Feb 9;16:22. doi: 10.1186/s12883-016-0540-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAPSYS-201205/08-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.